| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 1B | +7% |
| Gross Profit | 567.5MM | +13% |
| Cost Of Revenue | 445.6MM | - |
| Operating Income | 198.2MM | +50% |
| Operating Expenses | 369.3MM | +0% |
| Net Income | 246.5MM | -23% |
| R&D | 66.8MM | -8% |
| G&A | 111.8MM | +20% |
| Marketing | 148.9MM | +7% |
| Amortization | 13.3MM | - |
| Interest Expense | 26MM | -7% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Today we're going to take a look at the well-established Hologic, Inc. ( NASDAQ:HOLX ). The company's stock saw its...
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
Hologic (HOLX) concluded the recent trading session at $77.38, signifying a -0.77% move from its prior day's close.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The main point of investing for the long term is to make money. But more than that, you probably want to see it rise...